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Summary
The recruitment of basophils into the sites of allergic
inflammation is often observed. However, no defin-
itive evidence has been provided that basophils are
crucially involved in the pathogenesis of chronic al-
lergic disorders. Here, we show that basophils are re-
sponsible for the development of IgE-mediated chronic
allergic inflammation independently of T cells and mast
cells. A single subcutaneous injection of multivalent
antigens elicited not only immediate- and late-phase
ear swelling but also delayed-onset ear swelling with
massive eosinophil infiltration in mice sensitized with
antigen-specific IgE. Mast cells were essential for the
immediate- and late-phase ear swelling but dispens-
able for the delayed one. T cells were also dispens-
able for the latter. Transfer of FcRI-expressing baso-
phils into FcRI-deficient mice restored the development
of the delayed-onset allergic inflammation. These
findings indicate a novel mechanism of development
of chronic allergic inflammation that is induced by ba-
sophils through the interaction of antigen, IgE, and
FcRI.
Introduction
Allergen challenge of sensitized individuals can elicit
two types of allergic responses that occur typically in
a distinct temporal pattern: the immediate-phase reac-
tion develops within minutes of allergen exposure,*Correspondence: karasuyama.mbch@tmd.ac.jp
7 These authors contributed equally to this work.whereas the late-phase reaction develops within hours.
The major features of the immediate-phase reaction
and at least some features of the late-phase reaction
can be explained by the action of chemical mediators,
cytokines, and chemokines, released from mast cells,
and perhaps also from basophils, which become acti-
vated through IgE-mediated antigen stimulation (Galli
et al., 2005; Gould et al., 2003; Oettgen and Geha, 1999;
Turner and Kinet, 1999). In contrast, there is less agree-
ment about the importance of IgE and mast cells/baso-
phils in chronic allergic inflammation that can persist
for days to years as observed in chronic allergic disor-
ders such as asthma and atopic dermatitis (Leung and
Bieber, 2003; Oettgen and Geha, 2001; Umetsu et al.,
2002; Wedemeyer and Galli, 2000).
Both mast cells and basophils express the αβγ2 form
of FcRI on their surface and can be activated to
secrete an array of allergy mediators upon crosslinking
of FcRI bound IgE with antigens (Galli et al., 2005;
Gould et al., 2003; Oettgen and Geha, 1999; Turner and
Kinet, 1999). Despite these common features, they dif-
fer in natural history and localization. Mast cells typi-
cally do not circulate in the blood in mature state but
complete their differentiation in vascularized tissues
and have long life spans. On the other hand, basophils
typically mature in the bone marrow, then circulate in
the peripheral blood and have a short life span of sev-
eral days. They represent less than 1% of peripheral
blood leukocytes, making them one of the least com-
mon cell lineages found in the peripheral blood. There-
fore, basophils were often considered as minor and
possibly redundant “circulating mast cells.” The recent
finding that basophils readily generate large quantities
of Th2 cytokines has provided new insights into the
possible role of basophils in allergic diseases and im-
munity to pathogens (Falcone et al., 2000; Min et al.,
2004; Schroeder et al., 2001; Seder et al., 1991; Voeh-
ringer et al., 2004). However, no clear evidence has
been demonstrated that basophils play a crucial role in
the pathogenesis of chronic allergic disorders. This is
partly due to the limitations of allergy models available
to address the issue. Mutant mouse strains deficient
only in basophils have not yet been established.
It is generally considered that chronic allergic inflam-
mation is mediated mainly by T cells. Higher levels of
serum IgE in atopic patients could simply reflect the
increased expression of Th2 cytokines often observed
under allergic conditions. Interestingly, however, recent
clinical trials have demonstrated that the severity of
symptoms was improved by treatment with humanized
anti-IgE antibody not only in allergic rhinitis patients but
also in some poorly controlled asthma patients (Busse
et al., 2001; Holgate et al., 2004, 2005), indicating that
IgE may be involved in the pathogenesis of chronic al-
lergic inflammation.
We have previously established an allergy model in
mice carrying the transgene encoding IgE specific to
the hapten 2,4,6-trinitrophenol (TNP) (Matsuoka et al.,
1999). Intravenous injection of the corresponding anti-
gen elicits typical systemic anaphylaxis in these IgE
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192transgenic mice (Matsuoka et al., 1999). We found that o
Ia single subcutaneousinjection of the antigen without
any prior immunization elicited not only immediate-type a
obut also delayed-type ear swelling in these mice (Sato
et al., 2003). The immediate-phase (within 1 hr after an- T
ttigen challenge) ear swelling and the late-phase (6–10
hr) swelling were followed by much more intense swell- f
iing that began 2 days later and peaked on day 4. Mas-
sive infiltration of inflammatory cells, such as eosino- s
cphils and neutrophils, as well as hyperplastic epidermis
with hyperkeratosis were observed in the third-phase t
cear swelling. These findings suggested that IgE was in-
volved not only in immediate-type but also in chronic
aallergic inflammation under these experimental set-
tings. However, it remains to be determined how IgE A
bcontributes to chronic allergic inflammation.
In the present study, we defined cells and molecules C
tessential for the development of IgE-mediated chronic al-
lergic inflammation by analyzing a panel of mutant mice t
cand by performing cell transfer experiments. Unexpect-
edly, both mast cells and T cells were dispensable. We b
efound that high-affinity IgE receptor FcRI-expressing ba-
sophils were essential for the development of delayed- e
Ttype allergic inflammation even though they constituted
a minority of cells infiltrating into the skin lesions. These T
afindings unmasked the critical role of basophils in the
development of IgE/FcRI-mediated chronic allergic in- m
(flammation that is independent of T cells and mast
cells, raising the potential for new therapeutic strate- a
gies in chronic allergic disorders.
F
TResults
a
wT Cells Are Dispensable for IgE-Mediated Chronic
eAllergic Inflammation
IAs we reported previously (Sato et al., 2003), a single
csubcutaneous administration of TNP-conjugated oval-
pbumin (OVA), but not OVA, elicited triphasic ear swelling
lin unimmunized BALB/c mice carrying the TNP-specific
nIgE transgene (Figure 1A). The immediate-phase swell-
cing peaked within 1 hr after antigen challenge. The fol-
clowing late-phase (6–10 hr) swelling was less intense,
Iand the peak of the swelling was often obscure. The
cthird-phase swelling starting 1 or 2 days later was im-
amense and peaked on day 3 or 4, in that ears became
3congested (Figure 1B) and ear thickness became twice
hthe basal level or that of ears challenged with control
dOVA (Figure 1A). We found that a comparable triphasic
ear swelling was elicited when normal BALB/c or
C57BL/6 mice were pretreated with the intravenous ad- M
Wministration of TNP-specific IgE one day before antigen
challenge (Figures 1C and 2A). This reaction was not s
sdue to nonspecific stimulation by TNP-OVA or any im-
munomodulatory contaminant in the IgE sample, as the e
sTNP-OVA-induced ear swelling was not elicited in mice
untreated or pretreated with the same volume of asci- b
mtes containing comparable amounts of irrelevant IgE
(Figure 1C). Histopathological examination of the ear t
mskin in third-phase swelling revealed massive infiltra-
tion of inflammatory cells, including eosinophils and H
dneutrophils (Figure 2D, upper panels), as observed in
IgE transgenic mice (Sato et al., 2003). The magnitude Wf third-phase ear swelling correlated with the dose of
gE injected for sensitization as in the case of immedi-
te- and late-phase ear swelling, and as little as 11 g
f IgE could elicit third-phase ear swelling (Figure 1D).
he findings in nontransgenic mice indicated that the
hird-phase ear swelling was not an artifact derived
rom the transgenic expression of IgE and made it eas-
er to examine the incidence of the third-phase ear
welling in various mutant mice, avoiding tedious
rossbreeding with the transgenic mice. We designated
he third-phase ear swelling response as IgE-mediated
hronic allergic inflammation (IgE-CAI).
The two observations, the delayed onset of IgE-CAI
nd the efficient suppression of IgE-CAI by cyclosporin
(Sato et al., 2003), prompted us to examine the possi-
ility that T cells might play an important role in IgE-
AI even though the mice had not been sensitized with
he antigen prior to challenge. In contrast to our expec-
ations, RAG-2-deficient mice lacking both T and B
ells (Shinkai et al., 1992) developed IgE-CAI compara-
le to that observed in control normal mice in terms of
ar swelling and histopathological features, including
osinophil infiltration (Figures 2B and 2D, lower panels).
his was also the case in nude mice (data not shown).
hus, T cells were dispensable for IgE-CAI ear swelling
nd eosinophil infiltration. IgE-CAI was also elicited in
ice deficient for both RAG-2 and γc (Cao et al., 1995)
Figure 2C), indicating that NK and NKT cells were
lso dispensable.
cRI, but Not CD23, Is Essential for IgE-CAI
here are two types of IgE receptors: high-affinity FcRI
nd low-affinity CD23 (Gould et al., 2003). To determine
hich type is involved in IgE-CAI, mice deficient for
ither receptor were analyzed for their ability to develop
gE-CAI. CD23-deficient mice (Fujiwara et al., 1994)
ould mount all three types (immediate, late, and third
hase) of ear swelling, whereas FcRγ-deficient mice
acking FcRI expression (Takai et al., 1994) developed
one of them (Figures 3A and 3B). Furthermore, mice
arrying a transgene encoding either the human FcRIα
hain or humanized TNP-specific IgE did not develop
gE-CAI upon challenge with TNP-OVA, whereas those
arrying both of the transgenes did develop IgE-CAI
fter immediate- and late-phase ear swelling (Figure
C). These results clearly indicated that IgE and its
igh-affinity receptor FcRI played essential roles in the
evelopment of IgE-CAI.
ast Cells Are Dispensable for IgE-CAI
e reported previously that high-valence antigens
uch as TNP11-OVA, but not low-valence antigens
uch as TNP2-OVA and TNP5-OVA, elicited IgE-CAI
ven though both could induce immediate-type hyper-
ensitivity (Sato et al., 2003). We assumed that strong,
ut not milder, crosslinking of FcRI might stimulate
ast cells in the skin to produce higher levels or dis-
inct types of chemotactic factors that recruit inflam-
atory cells such as eosinophils to the site of IgE-CAI.
owever, WBB6F1-W/Wv mice deficient for mast cells
eveloped IgE-CAI comparable to that in control
BB6F1-+/+ mice (Figures 3D and 3E) even though the
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193former did not show immediate- or late-phase ear
swelling upon subcutaneous antigen challenge (Figure
3D) or systemic anaphylaxis upon intravenous antigen
challenge (data not shown), in contrast to the latter.
Thus, mast cells were essential for immediate- and
late-phase ear swelling but were dispensable for IgE-
CAI. T cell depletion by anti-CD3 mAb treatment did
not abolish IgE-CAI in WBB6F1-W/Wv mice (data not
shown), indicating that IgE-CAI could be developed in
the absence of both T cells and mast cells. Antigens
with high valence such as TNP11-OVA and TNP20-OVA,
but not those with low valence such as TNP2-OVA and
TNP4-OVA, elicited IgE-CAI in WBB6F1-W/Wv mice
(Figure 3F, not all data are shown) as observed in the
IgE transgenic mice (Sato et al., 2003).Figure 1. IgE-Mediated, Antigen-Specific Triphasic Ear Swelling
(A) The ear thickness of TNP-specific IgE transgenic BALB/c mice (n = 5) was measured at the indicated time points after subcutaneous
administration of 10 g of TNP11-OVA into the left ear (closed squares) and 10 g of OVA in the right ear (open circles). The kinetics of changes
in ear thickness after antigen challenge is shown. Data are expressed as the mean ± SEM and are representative of five repeated experiments.
(B) Photographs of right and left ears were taken 4 days after antigen challenge.
(C) Normal BALB/c mice (n = 5 in each group) were passively sensitized with i.v. injection of 200 l of diluted ascites containing 300 g of
TNP-specific IgE (left) or similarly diluted ascites containing comparable amounts of Cryj1-specific IgE (right) 1 day before the antigens were
administered as in (A). Unsensitized mice responded to the antigen challenge as those sensitized with Cryj1-specific IgE did (Sato et al., 2003).
(D) Normal BALB/c mice (n = 3 in each group) were passively sensitized with 300 (open circle), 100 (closed square), 33 (open diamond), or 11
(closed triangle) g of TNP-specific IgE 1 day before the antigens were administered as in (A). Thickness of left and right ears was measured
at the indicated time points. The values of Ear thickness, the differences in ear thickness (left − right) at each time point, are plotted. Data
are expressed as the mean ± SEM and are representative of three repeated experiments.Basophils Are Responsible for the Induction
of IgE-CAI
In addition to mast cells, basophils are also known to
express FcRI. However, in contrast to the case of mast
cells, we were not able to directly examine the inci-
dence of IgE-CAI in the absence of basophils, as mu-
tant mouse strains deficient only in basophils have not
yet been established. Furthermore, in humans, particu-
larly atopic patients, other cell types such as neutro-
phils, eosinophils, platelets, dendritic cells, and mono-
cytes/macrophages have also been shown to express
FcRI (Bieber et al., 1992; Gounni et al., 1994, 2001;
Joseph et al., 1997; Maurer et al., 1994). To clarify which
cell type is responsible for the induction of IgE-CAI, we
performed experiments with bone marrow chimeras.
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ttransferred to irradiated FcRγ−/− mice that were incapa-
ble of developing IgE-CAI due to the absence of FcRI. c
dThis transfer restored IgE-CAI when recipient mice
were analyzed 3 weeks after the transfer, whereas the c
ttransfer of bone marrow cells from FcRγ−/− mice did not
(Figure 4A). These results clearly indicated that FcRI- m
rexpressing hematopoietic cells derived from bone mar-
row were responsible for the development of IgE-CAI. c
iWe noticed that IgE-CAI could be induced in recipient
mice even when the antigen challenge was performed 4 t
idays after transfer of bone marrow cells (Figures 4B and
4C), suggesting that relatively differentiated cells in bone c
cmarrow could reconstitute IgE-CAI. Therefore, we frac-
tionated normal bone marrow cells on the basis of ex- w
npression of lineage markers and transferred each cell
fraction to FcRγ−/− mice. When bone marrow cells were oFigure 2. T Cells, B Cells, and NK Cells Are Dispensable for IgE-CAI
(A–C) Normal mice ([A], n = 5), RAG-2−/− ([B], n = 4), and RAG-2−/−γc−/− ([C], n = 4) mice on a C57BL/6 background were passively sensitized
with 300 g of TNP-specific IgE 1 day before subcutaneous administration of the antigens as shown in Figure 1. The kinetics of Ear
thickness after the antigen challenge is shown. Data are expressed as the mean ± SEM and are representative of three repeated experiments.
(D) In parallel experiments performed as described in (A) and (B), ear specimens were prepared from normal and RAG-2−/− mice and stained
with Giemsa 4 days after antigen challenge.epleted of NK cell marker DX5 (CD49b)-positive cells
hat constituted 3%–4% of nucleated cells, IgE-CAI
ould not be restored (Figure 4D). In contrast, those
epleted of cells positive for CD3, CD19, or NK1.1
ould restore IgE-CAI (data not shown). When the frac-
ion enriched for DX5+ cells in bone marrow from nor-
al mice was transferred together with total bone mar-
ow cells from FcRγ−/− mice that supplied other lineage
ells to irradiated recipient mice, IgE-CAI was restored
n the recipient mice (Figure 4D, and the titration of
ransferred DX5+ cells is shown in Figure S1 available
n the Supplemental Data with this article online). In
ontrast, normal bone marrow cells depleted of DX5+
ells did not restore IgE-CAI even when supplemented
ith total bone marrow cells from FcRγ−/− mice (data
ot shown). These results implied that the DX5+ fraction
f bone marrow cells from normal mice included cells
Basophils Initiate Chronic Allergic Inflammation
195Figure 3. FcRI Is Essential, but Mast Cells Are Dispensable for IgE-CAI
(A and B) Normal (open circles) and CD23−/− (closed squares) BALB/c mice (n = 4 each) (A) and normal (open circles) and FcRγ chain−/−
(closed squares) C57BL/6 mice (n = 5 each) (B) were treated as in Figure 2.
(C) BALB/c mice carrying the transgene encoding human FcRIα chain (n = 5, open circles), those carrying the transgene encoding humanized
TNP-specific IgE (n = 6, closed diamonds), and those carrying both of the transgenes (n = 8, closed squares) were challenged with the
antigens as shown in Figure 1A. The kinetics of Ear thickness after the antigen challenge is shown.
Data are representative of two, five, and three repeated experiments in (A), (B), and (C), respectively.
(D) WBB6F1- +/+ (open circles) and WBB6F1-W/Wv (closed squares) mice (n = 5 each) were treated as in Figure 2. The kinetics of Ear
thickness after antigen challenge is shown. Data are representative of five repeated experiments.
(E) In parallel experiments performed as in (D), ear specimens were prepared from WBB6F1-W/Wv mice and stained with Giemsa 4 days after
antigen challenge.
(F) WBB6F1-W/Wv mice were passively sensitized with IgE as in Figure 2 1 day before subcutaneous administration of 10 g of TNP11-OVA
(open circles) or TNP4-OVA (closed squares) in the left ears and control OVA in the right ears (n = 3 each). Data are representative of three
repeated experiments.
In (A)–(D) and (F) the error bars represent the mean ± SEM.that expressed FcRI and were responsible for the in-
duction of IgE-CAI.
Flow cytometric analyses revealed that 15%–25% of
DX5+ cells in normal bone marrow expressed FcRI
(Figure 5A). These cells were c-kit−, NK1.1−, CD3−,
B220−, Gr-1−, CD11c−, CD11bdull, 2B4+, and Thy-1.2+(Figure 5B), indicating that they were not mast cells, NK
cells, T cells, NKT cells, B cells, neutrophils, eosino-
phils, or dendritic cells. All these surface phenotypes
as well as their relatively low forward and side scatter
in flow cytometric analysis were consistent with the
characteristics described recently for mouse basophils
Immunity
196(
s
t
a
e
l
(
p
d
F
t
K
i
W
l
T
b
u
s
b
d
c
e
a
q
p
a
0
I
p
1
i
h
o
e
v
p
p
Figure 4. Transfer of DX5+ Normal Bone Marrow Cells Restores IgE-
t
vCAI in FcRγ Chain−/− Mice
(A and B) Bone marrow cells (5 × 107 cells per recipient) isolated Dfrom normal (closed squares) or FcRγ chain−/− (open circles)
C57BL/6 mice were transferred intravenously to six Gy-irradiated
FcRγ chain−/− C57BL/6 mice. 20 days (A) or 3 days (B) after transfer, F
the recipient mice were passively sensitized with IgE and chal- p
lenged with the antigens the next day as shown in Figure 2. The t
kinetics of Ear thickness after antigen challenge is shown. Data e
are expressed as the mean ± SEM of five mice in each group and
eare representative of three repeated experiments. In these experi-
cments as well as those shown in (D), we focused on the incidence
of IgE-CAI, and therefore, earlier kinetics of ear thickness is not l
plotted in the figures. 2
(C) In parallel experiments performed as in (B), ear specimens were r
prepared and stained with Giemsa 4 days after antigen challenge. b
(D) Bone marrow cells from C57BL/6 mice were fractionated with
tmagnetic beads on the basis of the surface expression of DX5.
fPre- and postfractionation profiles of DX5 expression are shown
on the left. On the right, the DX5− fraction (open circles; 5 × 107
cells per recipient, n = 5) or the DX5+ fraction (closed squares; 6 ×
106 cells per recipient, n = 3) was transferred to irradiated FcRγ
Cchain−/− mice. In the case of the DX5+ fraction, to supply cells of
other lineages to irradiated recipient mice, the total number of o
stransferred cells was adjusted to 5 × 107 by adding 4.4 × 107 FcRγ
chain−/− bone marrow cells that were incapable of restoring IgE- sMin et al., 2004; Voehringer et al., 2004). Light micro-
copic examination of sorted FcRI+DX5+ cells revealed
hat they possessed lobulated and often ring-like nuclei
nd few granules in the cytoplasm (Figure 5C). Further
lectron microscopic examination evidenced their lobu-
ated nuclei and characteristic electron-dense granules
Figure 5D), consistent with their identification as baso-
hils in the mouse (Dvorak, 2000; Min et al., 2004; Se-
er et al., 1991). Taken together, we concluded that
cRI+DX5+ basophils were responsible for the induc-
ion of IgE-CAI.
inetics of Cellular Infiltrates and IL-4 Expression
n the Skin Lesions of IgE-CAI
e examined kinetics of cells infiltrated into the skin
esions of IgE-CAI by using flow cytometry (Figure 6).
o distinguish mast cells and basophils among the IgE-
earing FcRI+ population, a surface marker c-kit was
sed instead of DX5 (Figure 6A), as mast cells in the
kin were found to express DX5 in contrast to those in
one marrow (data not shown). Basophils were indeed
etected in the skin lesions, and their numbers in-
reased along the development of IgE-CAI: 15–30 cells/
ar on day 0 and day1, 1500–2000 cells/ear on day 2,
nd 4000–6000 cells/ear on day 4. In terms of fre-
uency, however, basophils accounted for only a minor
opulation among the cells detected in the skin lesions:
pproximately 0.05%, 0.05%, 2%, 2%, and 2% on days
, 1, 2, 4, and 7 postchallenge, respectively (Figure 6B).
n contrast, eosinophils and neutrophils were the major
opulations, accounting for approximately 40% and
5%, respectively, on day 4, for example.
We next examined kinetics of IL-4 gene expression
n the skin lesions of IgE-CAI, because recent studies
ave demonstrated that basophils are the major source
f IL-4 (Min et al., 2004; Seder et al., 1991; Voehringer
t al., 2004). Semiquantitative RT-PCR analysis re-
ealed that IL-4 mRNA became detectable on day 2
ostchallenge concomitantly with the increase of baso-
hil numbers in the skin lesions (Figure 6C), suggesting
hat basophils infiltrated into the skin lesions were acti-
ated to produce IL-4 in the IgE-CAI reaction.
iscussion
or many years, basophils were thought to release only
reformed histamine and newly synthesized leuko-
riene C4 after activation by a variety of stimuli (Falcone
t al., 2000; Schroeder et al., 2001). There is now firm
vidence that basophils are also a major source of Th2
ytokines such as IL-4 and IL-13, key mediators of al-
ergic inflammation (Falcone et al., 2000; Min et al.,
004; Schroeder et al., 2001; Seder et al., 1991; Voeh-
inger et al., 2004). However, no definitive evidence has
een provided that basophils are crucially involved in
he pathogenesis of chronic allergic disorders. The
indings in the present study cast light on the role ofAI. The recipient mice were treated as shown in (B). The kinetics
f Ear thickness after antigen challenge is shown. Data are repre-
entative of three repeated experiments, and the error bars repre-
ent the mean ± SEM.
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197basophils in the development of chronic allergic inflam-
mation.
The IgE transgenic mice and normal mice sensitized
with IgE developed delayed-onset and long-lasting al-
lergic skin inflammation (IgE-CAI) characterized by
massive infiltration of eosinophils after the immediate-
and late-phase ear swelling upon single antigen chall-
enge. Mast cell-deficient mice could develop IgE-CAI
without showing the immediate- or late-phase ear swell-
ing. This indicated that mast cells were dispensable for
IgE-CAI and that the immediate- and late-phase reac-
tions mediated by mast cells were not prerequisites for
IgE-CAI. The time course of ear swelling in the IgE-CAI
reaction resembles that observed in the classical de-
layed-type hypersensitivity (DTH) reaction mediated by
T cells. However, there are several differences between
the two reactions. The cell types infiltrating the skin
lesions are distinct: eosinophils are rarely found in clas-
sical DTH (Gaga et al., 1991), whereas they were abun-
dant in IgE-CAI. IgE-CAI could be elicited in the ab-
sence of T cells in contrast to classical DTH. On theFigure 5. Characterization of FcRI+ Cells among the DX5+ Population in the Bone Marrow
(A) Bone marrow cells isolated from C57BL/6 mice were stained for DX5 and FcRI in combination with the panel of surface markers indicated
in (B).
(B) Dot plots were gated on DX5+ cells (R1 gate shown in [A]).
(C) DX5+FcRI+ cells were sorted from C57BL/6 bone marrow, and cytospin preparations were stained with Giemsa.
(D) DX5+ cells were isolated from bone marrow of RAG-2−/−γc−/− mice by using magnetic beads and subjected to electron microscopic exami-
nation.other hand, IgE was essential for IgE-CAI, but not for
classical DTH. Based on these differences, we con-
cluded that IgE-CAI is developed by a mechanism dis-
tinct from that of classical DTH.
IgE-CAI does not seem to belong to the type III hy-
persensitivity reaction. First, passive Arthus reaction
typically occurs several hours after antigen challenge
in the skin, much earlier than IgE-CAI. Second, as little
as 11 g of IgE was sufficient for sensitization to elicit
IgE-CAI. Third, IgE-CAI could be induced even when
the antigen was challenged 4 days after the sensitiza-
tion with 300 g of IgE (Figure S2). By that time, serum
IgE levels declined to less than 1 g/ml (Kubo et al.,
2003). Thus, high levels of IgE in serum at the time of
antigen challenge were not prerequisite for IgE-CAI.
Therefore, it is unlikely that the formation and local de-
position of immune complexes as observed in the type
III hypersensitivity is responsible for the induction of
IgE-CAI. Moreover, as IgE usually does not fix comple-
ment in contrast to IgG, complement activation is im-
probable even if the IgE-antigen immune complex is
Immunity
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formed, and it may not be crucial for the development t
of IgE-CAI. Indeed, C5-deficient mouse strains such as a
A/J and DBA/2J could develop IgE-CAI comparable to
that observed in C5-sufficient mouse strains such as p
BALB/c and C57BL/6 mice (Figure S3). a
We found that FcRI-bearing basophils were essen- p
tial for the development of IgE-CAI. Mouse basophils m
have been notoriously difficult to identify due to their c
few granules in contrast to their human counterparts t
(Dvorak, 2000). However, the recent characterization of t
surface markers, including DX5, has made it possible to t
identify and isolate mouse basophils by flow cytometry b
(Min et al., 2004; Voehringer et al., 2004). We demon- r
strated that FcRI-deficient mice could not develop p
IgE-CAI but that the transfer of bone marrow cells from t
normal mice restored the hypersensitivity reaction, indi- (
cating that FcRI-bearing hematopoietic cells were re- p
asponsible for IgE-CAI. Depletion of DX5+ cells from do-n
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Figure 6. Kinetics of Cellular Infiltrates and IL-4 Expression in the
cSkin Lesions of IgE-CAI
p(A) TNP-specific IgE transgenic mice were challenged with TNP-
zOVA as in Figure 1A. Cells were isolated from the ears by treatment
Twith collagenase at the time points indicated in (B) and incubated
with IgE at 4°C for 30 min to saturate FcRI. Subsequently, cells d
were stained for IgE, Gr-1, and c-kit. Dot plots show flow cytomet- t
ric analysis of ear samples prepared 4 days after the antigen chal- p
lenge. c-kit staining profile of IgEhighGr-1− cells gated as shown in t
the upper panel is shown in the lower panel.
f(B) Cell numbers of each cell lineage recovered from one ear at the
oindicated time points after antigen challenge were calculated from
sthe results shown in (A) and are displayed as a bar graph. Mast
cells, basophils, eosinophils, and neutrophils were defined as n
IgE+c-kit+ cells, IgE+c-kit− cells, IgE−Gr-1low cells, and IgE−Gr-1high (
cells, respectively. Data are representative of three repeated exper- o
iments. l(C) Semiquantitative RT-PCR analysis for IL-4 gene expression was
aperformed by using RNA prepared from cells that were isolated
sfrom the ears at the indicated time points as described in (A) and
i(B). PCR templates were 2-fold serially diluted.
cor cells abolished the restoration, whereas transfer of
X5+ bone marrow cells restored IgE-CAI in FcRI-defi-
ient mice. w20% of the DX5+ bone marrow cells were
hown to express FcRI and other surface markers as
ell as morphological characteristics that were consis-
ent with their identification as basophils. We could not
dentify any other lineage cells expressing FcRI among
he DX5+ bone marrow cells. Taken together, we con-
luded that FcRI+DX5+ basophils were responsible for
he development of IgE-CAI. Cells possessing the phe-
otype comparable to that of bone marrow basophils
ere detected in spleen and peripheral blood, albeit
uch less in number than in bone marrow. Transfer of
X5+ spleen cells including basophils from normal mice
o FcRI-deficient mice failed to restore IgE-CAI in the
ange of cell numbers we could transfer (data not
hown). We assume that the average life span of pe-
ipheral basophils might be too short to complete IgE-
AI as compared to that of newly generated basophils
n bone marrow. Alternatively, peripheral basophils
ight be more sensitive to the cell damage caused by
he cell isolation procedure than bone marrow baso-
hils.
It has been demonstrated that cutaneous DTH con-
aining large basophil infiltrates, termed Jones-Mote
ypersensitivity in humans (Jones and Mote, 1934) or
utaneous basophil hypersensitivity (CBH) in guinea
igs (Richerson et al., 1970), can be elicited by immuni-
ation with proteins without mycobacterial adjuvants.
he reported features of this type of DTH appear to be
istinct from those of IgE-CAI. First, basophils consti-
ute as much as 80% of the dermal infiltrates in guinea
ig CBH, whereas they account for less than 2% of
hose in IgE-CAI. Second, CBH peaks at 18–24 hr and
ades by 48 hr, much earlier than IgE-CAI. Third, it was
riginally reported that CBH could be transferred pas-
ively with lymphocytes from sensitized animals, but
ot with their serum as in the case of classical DTH
Dvorak et al., 1971). Later studies indicated that IgG1
r IgE from sensitized guinea pigs could transfer a de-
ayed-onset basophil-containing reaction (Graziano et
l., 1983; Haynes et al., 1978), but this appeared to be
imilar to the late-phase reaction of the IgE-mediated
mmediate-type allergic response. Taken together, we
oncluded that IgE-CAI was distinct from CBH. It re-
ains to be determined whether the difference of these
wo reactions is attributed to species difference or
mounts of antibodies used.
The present study unmasked the critical role of baso-
hils in the development of IgE/FcRI-mediated chronic
llergic inflammation that is T cell and mast cell inde-
endent. Importantly, basophils accounted for only a
inor population of the infiltrating cells in IgE-CAI in
ontrast to the large numbers of eosinophils and neu-
rophils. Therefore, we assume that basophils are initia-
ors or propagators rather than effectors of inflamma-
ion, even though the detailed mode of action of
asophils in IgE-CAI-type chronic allergic inflammation
emains to be determined. It has been shown that de-
letion of basophils diminishes eosinophil infiltration at
he site of inflammation in tick infection of guinea pigs
Brown et al., 1982), suggesting that activated baso-
hils secrete cytokines or chemokines to recruit and
ctivate eosinophils and perhaps other inflammatory
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199cells. Upon stimulation, basophils have been shown to
rapidly produce large amounts of Th2 cytokines such
as IL-4 and IL-13, which are key mediators of allergic
inflammation (Falcone et al., 2000; Min et al., 2004;
Schroeder et al., 2001; Seder et al., 1991; Voehringer et
al., 2004). Indeed, IL-4 expression became detectable
in the skin lesions of IgE-CAI concomitantly with the
increase of basophil numbers infiltrated in the skin. The
transgenic expression of IL-4 or IL-13 in the mouse lung
resulted in eosinophil infiltration (Rankin et al., 1996;
Zhu et al., 1999), and both cytokines have been shown
to promote the production of eotaxin, an eosinophil
chemoattractant, in airway epithelial cells or dermal fi-
broblasts (Li et al., 1999; Mochizuki et al., 1998). Thus,
basophils appear to play an important role in allergic
inflammation beyond their recognized role as effector
cells (Falcone et al., 2000; Marone et al., 2005; Prussin
and Metcalfe, 2003; Schroeder et al., 2001). We are cur-
rently analyzing with DNA microarray and a panel of
mutant mice what kinds of cytokines, chemokines, and
chemical mediators are released from basophils in IgE-
CAI and which is crucial for recruitment of other inflam-
matory cells. Preliminary results using mutant mice
suggested that IL-4 was dispensable for IgE-CAI (data
not shown).
It remains to be determined how basophils are re-
cruited to the sites of antigen exposure to initiate IgE-
CAI. We noticed that the intradermal injection of OVA
induced mild infiltration of cells such as neutrophils,
which was detected on day 1 but subsided by day 2
(data not shown). Therefore, it is plausible that intrader-
mal injection of antigens nonspecifically stimulates
dendritic cells, macrophages, keratinocytes, fibroblasts,
or other cells in the skin to transiently produce chemo-
tactic factors that recruit inflammatory cells, including
basophils. Then, TNP-OVA, but not OVA, might stimu-
late such recruited basophils via TNP-specific IgE
bound to their surface to initiate IgE-CAI.
High valency of antigens was necessary to elicit IgE-
CAI (Figure 3F), whereas both low- and high-valence
antigens could elicit immediate-type hypersensitivity
(Sato et al., 2003). Therefore, there appears to be a
threshold in signal strength to stimulate basophils to
develop IgE-CAI. In in vitro experiments, binding of
TNP11-OVA induced much stronger downmodulation
of IgE-FcRI complexes on the surface of bone marrow
basophils than that of TNP4-OVA did (data not shown).
Thus, we speculate that the stronger crosslinking of
FcRI with TNP11-OVA stimulates basophils to secrete
higher levels or distinct types of cytokines or chemo-
kines necessary for the development of IgE-CAI. Mole-
cules possessing repetitive epitopes like TNP11-OVA
might not be found so frequently among allergens in
real life. However, in contrast to mice sensitized with
monoclonal IgE, allergic patients could produce poly-
clonal IgE against a given allergen. A grass pollen aller-
gen has been shown to have at least nine different epi-
topes recognized by patient serum IgE (Schramm et al.,
2001). Thus, it would be intriguing to examine whether
such polyvalent antigens can stimulate basophils via
polyclonal IgE bound to their surface to induce the IgE-
CAI-type reaction.
A number of cohort studies indicated that there was
a correlation between the disease severity and serumIgE levels in patients with asthma or atopic dermatitis,
especially in younger people (Burrows et al., 1989;
Schafer et al., 1999). Recent clinical trials have indi-
cated that the rapid and pronounced decrease in serum
IgE level achieved by treatment with humanized anti-
IgE antibody (omalizumab) is correlated with improve-
ment of the severity of symptoms not only in allergic
rhinitis patients but also in some poorly controlled
asthma patients, leading to a reduction in the require-
ment for inhaled corticosteroids (Busse et al., 2001;
Holgate et al., 2004, 2005). This suggests that IgE may
be involved in the pathogenesis of chronic allergic in-
flammation in humans. Based on the present observa-
tions in the mouse model, we speculate that IgE-CAI
might contribute to the initiation, prolongation, or dete-
rioration of chronic allergic inflammation in a certain
type of asthma and atopic dermatitis.
Corticosteroids and immunosuppressants are widely
used for the treatment of chronic allergic disorders. We
reported previously that cyclosporin A almost com-
pletely suppressed IgE-CAI in IgE transgenic mice
(Sato et al., 2003). Although the main action of cyclo-
sporin A has been demonstrated to be suppression of
the transcription of cytokine genes in activated T cells,
it has also been reported to have effects on basophils
(Genovese et al., 2003; Hultsch et al., 1990; Plath et al.,
2003). These results suggest that basophils and their
products might be good targets to control IgE-CAI-type
chronic allergic inflammation. Further detailed studies
on IgE-CAI should help to develop novel therapeutic
strategies for the treatment of chronic allergic dis-
orders.
In conclusion, to our knowledge, we have defined a
previously unknown in vivo function of basophils, namely,
initiating IgE-mediated chronic allergic inflammation in-
dependently of T cells and mast cells. Previous studies
suggested that FcRI-IgE-antigen complexes on hu-
man antigen presenting cells such as Langerhans cells
facilitate antigen uptake and antigen presentation to T
cells and, hence, contribute to T cell-mediated chronic
allergic inflammation (Bieber, 1997; von Bubnoff et al.,
2003). The present study proposes a novel mechanism
whereby IgE contributes the development or deteriora-
tion of chronic allergic inflammation through activation
of basophils in a T cell- and mast cell-independent
manner.
Experimental Procedures
Mice
BALB/c and C57BL/6 mice were purchased from Charles River Ja-
pan (Yokohama, Japan). FcRγ chain−/− C57BL/6 mice (Takai et al.,
1994) were from Jackson Laboratory (Bar Harbor, ME). RAG-2−/−
γc−/−(y) C57BL/6 mice (Cao et al., 1995) were from Taconic (German-
town, NY). A/J, WBB6F1- +/+, and WBB6F1-W/Wv mice were from
Japan SLC (Hamamatsu, Japan). DBA/2J mice were from CLEA
Japan (Tokyo, Japan). RAG-2−/− C57BL/6 mice (Shinkai et al., 1992),
CD23−/− BALB/c mice (Fujiwara et al., 1994), and TNP-specific IgE
transgenic BALB/c mice (Matsuoka et al., 1999) were described
previously. BALB/c mice carrying a humanized IgE transgene were
established by replacing the constant region of the H chain gene
encoding TNP-specific mouse IgE with the human counterpart. Hu-
man FcRIα chain transgenic mice were established by microinjec-
tion of the 17 kb BamHI fragment of the genomic DNA encoding
human FcRIα chain into fertilized eggs of BALB/c mice. Mice were
maintained under specific pathogen-free conditions in our animal
Immunity
200facility. All the experiments in this study were performed according i
Cto the Guidelines for Animal Use and Experimentation as set out
by our University. T
T
Antibodies
Biotinylated mAbs specific for mouse IgE (R35-72), Thy1.2 (30-
H12), and DX5 (DX5) and FITC-conjugated and PE-conjugated S
mAbs specific for DX5 (DX5) and c-kit (ACK45) were purchased S
from BD Pharmingen (San Diego, CA). Biotinylated mAbs specific a
for CD3 (145-2C11), CD11c (HL3), Gr-1 (RB6-8C5), B220 (RA3-6B2), 1
NK1.1 (PK136), 2B4 (2B4), CD11b (M1/70), and c-kit (2B8), and
FITC-conjugated anti-Gr-1 mAb (RB6-8C5) and PE-conjugated A
anti-mouse FcRIα (MAR-1) were purchased from eBioscience (San
Diego, CA). W
R
Elicitation and Measurement of Antigen-Induced Ear Swelling a
Antigen TNP-conjugated OVA was purchased from Biosearch Tech- p
nologies (Novato, CA). TNP11-OVA and TNP4-OVA were used for T
the experiments. Mice were sensitized with IgE by intravenous in- a
jection of diluted ascites (200 l) containing indicated amounts of o
TNP-specific IgE derived from IGELb4 B cell hybridoma (Rudolph H
et al., 1981) or comparable amounts of irrelevant IgE that is specific
to cedar pollen antigen Cryj1 (K.M., H.Y., and H.K., unpublished
Rdata) 1 day before antigen challenge. In the case of TNP-specific
RIgE transgenic mice, this sensitization with exogenous IgE was
Aomitted. The left ears of mice were administered subcutaneously
Pwith 10 g of TNP-OVA in 10 l of PBS, and their right ears were
administered an equal amount of OVA by using a microsyringe un-
Rder light anesthesia with diethyl ether. Ear thickness was measured
with a dial thickness gauge (G-1A; Ozaki, Tokyo, Japan).
B
nFractionation and Transfer of Bone Marrow Cells
BSingle-cell suspensions prepared from bone marrow were reacted
Rwith biotinylated mAbs at 4°C for 30 min, followed by incubation
Lwith streptavidin-conjugated microbeads (Miltenyi Biotec, Bergisch
gGladbach, Germany) for 15 min. Positive and negative fractions
were isolated separately by autoMACS (Miltenyi Biotec). Total or B
fractionated bone marrow cells (5 × 107 cells per recipient) from l
C57BL/6 mice were transferred to six Gy-irradiated FcRγ−/− mice. r
At the indicated time points after bone marrow transfer, the recipi- o
ent mice were sensitized with IgE followed by antigen challenge. 7
B
Histological, Flow Cytometric, and Electron M
Microscopic Analysis t
Ear specimens were fixed with 10% formalin and embedded in par-
Baffin. Sections were stained with Giemsa for histological examina-
Ction under a microscope. For flow cytometric analysis, ears re-
Imoved from mice were treated with collagenase type III (125 U/ml,
oWorthington Biochemical Corporation, Lakewood, NJ) in RPMI
Ccomplete medium for 2 hr at 37°C to obtain single-cell suspen-
Ssions. Cells prepared from ears and bone marrow were depleted of
DRBC by lysis with hypotonic buffer and preincubated with anti-
cCD16/32 (2.4G2) mAb (BD PharMingen) and normal rat serum on
ice for 15 min to prevent nonspecific binding of other Abs. Remain- D
ing cells were stained with the indicated combinations of Abs and n
analyzed with FACSCalibur (BD Biosciences, Mountain View, CA). D
DX5+FcRI+ cells were sorted from bone marrow cells with FACS- (
Vantage (BD Biosciences), and cytospin preparations (Cytospin 2; b
Thermo Shandon, Runcorn, UK) were stained with Giemsa. DX5+ l
cells were isolated from bone marrow cells with autoMACS (Mil- m
tenyi Biotec) and fixed with 2% glutaraldehyde, postfixed with 1%
FOsO4, and embedded in Epon. Ultrathin sections were double
pstained with uranyl acetate and lead citrate and examined with a
4JEM 1200EX transmission electron microscopy (JEOL, Tokyo,
FJapan).
s
aSemiquantitative RT-PCR Analysis
iTotal RNA was prepared from cells that were isolated from the ears
Uof mice as for flow cytometric analysis and subjected to the first
strand cDNA synthesis with reverse transcription using oligo-dT G
aprimers. PCR was performed with 2-fold serially diluted cDNA tem-
plates at 94°C for 30 s, 60°C for 30 s, and 72°C for 60 s for 30 p
Icycles, followed by further extension at 72°C for 5 min. The follow-ng primers were used for PCR: for IL-4 forward, 5#-GAGCCATATC
ACGGATGCGACAA-3# and reverse, 5#-CATGGTGGCTCAGTAC
ACGAGTA-3# and for HPRT forward, 5#-GCTGGTGAAAAGGACC
CT-3# and reverse, 5#-CACAGGACTAGAACACCTGC-3#.
upplemental Data
upplemental Data include three figures and are available with this
rticle online at http://www.immunity.com/cgi/content/full/23/2/
91/DC1/.
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